SIDE EFFECTS

 

Associated with Discontinuation of Treatment

Of the 1087 OCD and depressed patients treated with fluvoxamine maleate in controlled clinical trials conducted in North America, 22% discontinued treatment due to an adverse event. The most common events (> 1%,) associated with discontinuation and considered to be drug related (i.e., those events associated with dropout at a rate at least twice that of placebo) included:

Table 1: ADVERSE EVENTS ASSOCIATED WITH DISCONTINUATION OF TREATMENT IN OCD AND DEPRESSION POPULATIONS

BODY SYSTEM

ADVERSE EVENT

PERCENTAGE OF PATIENTS

FLUVOXAMINE

PLACEBO
BODY AS A WHOLE  
Headache

3%

1%
Asthenia

2%

<1%
Abdominal Pain

1%

0%
DIGESTIVE  
Nausea

0%

1%
Diarrhea

1%

<1%
Vomiting

2%

<1%
Anorexia

1%

<1%
Dyspepsia

1%

<1%
NERVOUS SYSTEM  
Insomnia

4%

1%
Somnolence

4%

<1%
Nervousness

2%

<1%
Agitation

2%

<1%
Dizziness

2%

<1%
Anxiety

1%

<1%
Dry Mouth

1%

<1%

 

Luvox's Half-Life & Average Time to Clear Out of Your System: 15.6 hours, the shortest of all true SSRIs.

 

Back to Luvox Main Page